Emerging leader in diagnostic testing accelerates growth and product launch with clinivation’s Integrated Approval and Quality solutions.
Framingham, MA, June 20, 2005 – clinivation, Inc. announced today that SDS, Inc. (NASDAQ: SVAD.OB) has selected clinivation’s integrated approval and quality systems infrastructure and process solutions.
“SDS is an emerging leader in next-generation diagnostic testing applications for important infectious diseases and other medical conditions,” said Joseph Kozikowski, M.D., clinivation’s Founder, Chairman, and Chief Executive Officer. “We are pleased that SDS’s senior management has selected clinivation to help extend their quality systems and position their manufacturing and development operations for continued growth and upcoming regulatory approvals,” he continued.
Clinivation’s Approvals Practice delivers regulatory expertise, development strategy, and an outstanding track record. Clinivation’s rapidly-implementable quality systems infrastructure solutions are pre-configured, matched to specific client needs, and designed to scale with product history and organization growth.
About SDS, Inc.
SDS, Inc. is dedicated to developing reliable, affordable, rapid diagnostic tests for infectious diseases and other conditions for which there is a demonstrated market.
For more information about SDS, visit the company website at www.salv.com
